Podcast 19: Re-configuring Global Pharma Supply Chains

In this podcast, we feature an article that looks at the policy debate to repatriate and increase domestic drug manufacturing in the US in light of the COVID-19 pandemic and pharmaceutical supply-chain vulnerabilities. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

  • A plan for addressing supply-chain vulnerabilities in the US
  • Legislative proposals in the US
Leave a Reply

Your email address will not be published. Required fields are marked *